Cargando...
Dengvaxia: the world’s first vaccine for prevention of secondary dengue
The objective of this manuscript was to review and evaluate the efficacy and safety data of Dengvaxia for the treatment of severe secondary dengue infection. Dengvaxia is the brand name for chimeric yellow fever-dengue-tetravalent dengue vaccine (CYD-TDV). A literature search through PubMed was cond...
Gardado en:
| Publicado en: | Ther Adv Vaccines Immunother |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8132086/ https://ncbi.nlm.nih.gov/pubmed/34036241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/25151355211015839 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|